JP Morgan Maintains Overweight on Adient, Lowers Price Target to $23
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $25 to $23.
JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $25 to $23.